Virax Biolabs Group Limited (VRAX)

NASDAQ: VRAX · IEX Real-Time Price · USD

1.350

+0.180 (15.38%)

At close: Jul 26, 2024, 3:58 PM

1.290

-0.060 (-4.44%)

After-hours: Jul 26, 2024, 5:49 PM EDT

Virax Biolabs Group Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year Ending	TTM	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Revenue	0.08	0.01	-	0.12	0.1
Revenue Growth (YoY)	1276.75%	-	-	23.97%	-
Cost of Revenue	0.07	0.01	-	0.13	0.05
Gross Profit	0.01	-0	-	-0.01	0.05
Selling, General & Admin	6.3	5.33	1.3	0.51	0.61
Research & Development	0.71	0.4	0.43	0.12	0.09
Operating Expenses	7.01	5.73	1.73	0.64	0.7
Operating Income	-7	-5.73	-1.73	-0.64	-0.65
Interest Expense	-0.02	-0.02	-0.02	-0.03	-0.09
Other Non Operating Income (Expenses)	0.29	0.29	-0	0	0
EBT Excluding Unusual Items	-6.72	-	-	-	-
Other Unusual Items	-0.2	-	-	-	-
Pretax Income	-6.92	-5.46	-1.75	-0.67	-0.74
Earnings From Continuing Operations	-6.92	-5.46	-1.75	-0.67	-0.74
Minority Interest in Earnings	-0.01	0	0.04	0.02	0.03
Net Income	-6.92	-5.46	-1.71	-0.65	-0.71
Net Income to Common	-6.92	-5.46	-1.71	-0.65	-0.71
Shares Outstanding (Basic)	2	1	1	0	0
Shares Outstanding (Diluted)	2	1	1	0	0
Shares Change (YoY)	55.33%	11.15%	297.67%	130.43%	-
EPS (Basic)	-3.82	-5.13	-1.79	-2.71	-6.81
EPS (Diluted)	-3.82	-5.13	-1.80	-2.71	-6.81
Free Cash Flow	-5.83	-4.18	-0.81	-0.59	-0.74
Free Cash Flow Per Share	-3.22	-3.93	-0.85	-2.45	-7.13
Gross Margin	11.39%	-15.94%	-	-7.62%	45.81%
Operating Margin	-8825.12%	-66963.68%	-	-520.54%	-652.05%
Free Cash Flow Margin	-7356.16%	-48823.35%	-	-476.65%	-745.54%
EBIT	-7	-5.73	-1.73	-0.64	-0.65
Revenue as Reported	-	-	-	0.12	0.1

Source: S&P Capital IQ. Standard template.